Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW

UKONIQ UMBRALISIB厄布利塞

UKONIQ-UMBRALISIB INSTRUCTIONS
Ukoniq (umbralisib) indications
UKONIQ is a kinase inhibitor indicated for adult patients with:

• Relapsed or refractory marginal zone lymphoma (MZL) who have received at least one prior anti-CD20-based therapy.

• Relapsed or refractory follicular lymphoma (FL) who have received at least three prior systemic therapies.

Categories:

Share: